FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1519934593> ?p ?o ?g. }

• W1519934593 endingPage "1821" @default.
• W1519934593 startingPage "1816" @default.
• W1519934593 abstract "Background Glembatumumab vedotin is an antibody-auristatin conjugate that targets cells expressing the transmembrane glycoprotein NMB (GPNMB, also known as osteoactivin). It has entered clinical evaluation for adult cancers that express GPNMB, including melanoma and breast cancer. Procedures Glembatumumab vedotin was administered intravenously at a dose of 2.5 mg/kg using a weekly × 3 schedule, and its antitumor activity was evaluated against selected Pediatric Preclinical Testing Program (PPTP) solid tumor xenografts using standard PPTP response metrics. Results Among PPTP xenografts, GPNMB was primarily expressed on the osteosarcoma xenografts, all of which expressed GPNMB at the RNA level, although at varying levels. Protein expression assessed by immunohistochemistry (IHC) showed variation across the osteosarcoma xenografts with one model showing no tumor cell expression. Glembatumumab vedotin induced statistically significant differences (P < 0.05) in event-free survival (EFS) distribution compared to control in each of the six osteosarcoma models studied. Three of six osteosarcoma xenografts demonstrated a maintained complete response (MCR). Two other xenografts showed progressive disease with growth delay, while the final xenograft showed progressive disease with no growth delay. Two of the osteosarcoma xenografts with MCRs showed the highest GPNMB expression at the RNA level. Conversely, the xenograft with the lowest GPNMB mRNA expression had the poorest response to glembatumumab vedotin. Two rhabdomyosarcoma xenografts that did not express GPNMB showed limited responses to glembatumumab vedotin. Conclusions Glembatumumab vedotin yielded high-level activity against three of six osteosarcoma xenografts, with evidence for response being related to GPNMB expression levels. Pediatr Blood Cancer 2014; 61:1816–1821. © 2014 Wiley Periodicals, Inc." @default.
• W1519934593 created "2016-06-24" @default.
• W1519934593 creator A5009981843 @default.
• W1519934593 creator A5032743242 @default.
• W1519934593 creator A5046943976 @default.
• W1519934593 creator A5048193615 @default.
• W1519934593 creator A5063003513 @default.
• W1519934593 creator A5073277560 @default.
• W1519934593 creator A5077196075 @default.
• W1519934593 date "2014-06-09" @default.
• W1519934593 modified "2023-10-16" @default.
• W1519934593 title "Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program" @default.
• W1519934593 cites W1571073982 @default.
• W1519934593 cites W1841030713 @default.
• W1519934593 cites W1912834410 @default.
• W1519934593 cites W1964475719 @default.
• W1519934593 cites W1966693183 @default.
• W1519934593 cites W1973158710 @default.
• W1519934593 cites W2017712784 @default.
• W1519934593 cites W2018887623 @default.
• W1519934593 cites W2023471324 @default.
• W1519934593 cites W2059629688 @default.
• W1519934593 cites W2059841622 @default.
• W1519934593 cites W2083670340 @default.
• W1519934593 cites W2089863851 @default.
• W1519934593 cites W2089941969 @default.
• W1519934593 cites W2091213994 @default.
• W1519934593 cites W2095911832 @default.
• W1519934593 cites W2104953667 @default.
• W1519934593 cites W2106529185 @default.
• W1519934593 cites W2110462280 @default.
• W1519934593 cites W2118472540 @default.
• W1519934593 cites W2123001989 @default.
• W1519934593 cites W2138852752 @default.
• W1519934593 cites W2164650822 @default.
• W1519934593 cites W2164829453 @default.
• W1519934593 cites W2293532321 @default.
• W1519934593 cites W2517870508 @default.
• W1519934593 doi "https://doi.org/10.1002/pbc.25099" @default.
• W1519934593 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4280502" @default.
• W1519934593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24912408" @default.
• W1519934593 hasPublicationYear "2014" @default.
• W1519934593 type Work @default.
• W1519934593 sameAs 1519934593 @default.
• W1519934593 citedByCount "33" @default.
• W1519934593 countsByYear W15199345932015 @default.
• W1519934593 countsByYear W15199345932016 @default.
• W1519934593 countsByYear W15199345932017 @default.
• W1519934593 countsByYear W15199345932018 @default.
• W1519934593 countsByYear W15199345932019 @default.
• W1519934593 countsByYear W15199345932020 @default.
• W1519934593 countsByYear W15199345932021 @default.
• W1519934593 countsByYear W15199345932022 @default.
• W1519934593 countsByYear W15199345932023 @default.
• W1519934593 crossrefType "journal-article" @default.
• W1519934593 hasAuthorship W1519934593A5009981843 @default.
• W1519934593 hasAuthorship W1519934593A5032743242 @default.
• W1519934593 hasAuthorship W1519934593A5046943976 @default.
• W1519934593 hasAuthorship W1519934593A5048193615 @default.
• W1519934593 hasAuthorship W1519934593A5063003513 @default.
• W1519934593 hasAuthorship W1519934593A5073277560 @default.
• W1519934593 hasAuthorship W1519934593A5077196075 @default.
• W1519934593 hasBestOaLocation W15199345932 @default.
• W1519934593 hasConcept C121608353 @default.
• W1519934593 hasConcept C126322002 @default.
• W1519934593 hasConcept C142724271 @default.
• W1519934593 hasConcept C143998085 @default.
• W1519934593 hasConcept C204232928 @default.
• W1519934593 hasConcept C2775999222 @default.
• W1519934593 hasConcept C2777760704 @default.
• W1519934593 hasConcept C2778256501 @default.
• W1519934593 hasConcept C2780844630 @default.
• W1519934593 hasConcept C502942594 @default.
• W1519934593 hasConcept C71924100 @default.
• W1519934593 hasConceptScore W1519934593C121608353 @default.
• W1519934593 hasConceptScore W1519934593C126322002 @default.
• W1519934593 hasConceptScore W1519934593C142724271 @default.
• W1519934593 hasConceptScore W1519934593C143998085 @default.
• W1519934593 hasConceptScore W1519934593C204232928 @default.
• W1519934593 hasConceptScore W1519934593C2775999222 @default.
• W1519934593 hasConceptScore W1519934593C2777760704 @default.
• W1519934593 hasConceptScore W1519934593C2778256501 @default.
• W1519934593 hasConceptScore W1519934593C2780844630 @default.
• W1519934593 hasConceptScore W1519934593C502942594 @default.
• W1519934593 hasConceptScore W1519934593C71924100 @default.
• W1519934593 hasFunder F4320337351 @default.
• W1519934593 hasIssue "10" @default.
• W1519934593 hasLocation W15199345931 @default.
• W1519934593 hasLocation W15199345932 @default.
• W1519934593 hasLocation W15199345933 @default.
• W1519934593 hasLocation W15199345934 @default.
• W1519934593 hasOpenAccess W1519934593 @default.
• W1519934593 hasPrimaryLocation W15199345931 @default.
• W1519934593 hasRelatedWork W2001379878 @default.
• W1519934593 hasRelatedWork W2094855561 @default.
• W1519934593 hasRelatedWork W2126279340 @default.
• W1519934593 hasRelatedWork W2132781781 @default.
• W1519934593 hasRelatedWork W228711004 @default.

• next